首页> 外文期刊>Modern Pathology >Biotinyl-Tyramide-Based In Situ Hybridization Signal Patterns Distinguish Human Papillomavirus Type and Grade of Cervical Intraepithelial Neoplasia
【24h】

Biotinyl-Tyramide-Based In Situ Hybridization Signal Patterns Distinguish Human Papillomavirus Type and Grade of Cervical Intraepithelial Neoplasia

机译:基于生物素-Tyramide的原位杂交信号模式区分人乳头瘤病毒类型和宫颈上皮内瘤变的等级

获取原文
           

摘要

In this study, the prevalence of human papillomavirus integration in cervical intraepithelial neoplasia Grades I, II, and III has been investigated using a highly sensitive biotinyl-tyramide–based in situ hybridization methodology. This method is able to demonstrate integrated viral DNA by punctate signals within the nucleus and episomal viral DNA by a diffuse signal throughout the nucleus. Fifteen viral types were identified by General Primer 5+/6+ polymerase chain reaction assay among 26 Grade I and 22 Grade II/III lesions. High-risk human papillomavirus (Types 16, 18, 31, 33, 35, 39, 45, 51, 52, 56, 58, and 66) was found in 20 (77%) Grade I and in 22 (100%) Grade II/III lesions (P =.025). Human papillomavirus Type 16 was identified in 2 (7%) Grade I and in 15 (68%) Grade II/III samples (P in situ hybridization to address key issues concerning the biology of cervical intraepithelial neoplasia.
机译:在这项研究中,已经使用高度敏感的基于生物素-酪酰胺的原位杂交方法研究了人乳头瘤病毒整合在宫颈上皮内瘤变I,II和III中的普遍性。该方法能够通过点缀核内的信号来证明整合的病毒DNA,并通过遍布整个核内的弥散信号来证明游离型病毒DNA。通过通用引物5 + / 6 +聚合酶链反应测定法在26个I级和22级II / III级病变中鉴定出15种病毒类型。在20级(77%)和22级(100%)中发现了高风险的人乳头瘤病毒(16、18、31、33、35、39、45、51、52、56、58和66型) )II / III级病变(P = .025)。在2个(7%)的I级和15个(68%)的II / III级样本中鉴定了16型人乳头瘤病毒(P原位杂交,以解决与宫颈上皮内瘤变生物学相关的关键问题。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号